| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |